U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. Former Traveling Nurse Pleads Guilty to Tampering with Morphine
  1. Press Releases

Former Traveling Nurse Pleads Guilty to Tampering with Morphine

OCI badge

Department of Justice
U.S. Attorney's Office
District of Massachusetts 

FOR IMMEDIATE RELEASE
Thursday, November 7, 2024

 

BOSTON – A former traveling nurse pleaded guilty yesterday in federal court in Boston to tampering with morphine at a local rehabilitation facility.

Loralie LaBroad, 54, of Hampton, N.H., pleaded guilty to one count of tampering with a consumer product. U.S. District Judge Julia E. Kobick scheduled sentencing for Feb. 21, 2025. LaBroad was charged by in September 2024.

According to charging documents, while working as a traveling nurse assigned to a rehabilitation center, LaBroad tampered with two bottles of morphine on the medication cart she was assigned. LaBroad used a syringe to remove morphine from the bottles, injected another liquid substance into the bottles to replace the morphine she had removed, and returned the bottles to the medication cart. Investigators seized the bottles immediately after her shift and laboratory testing confirmed that the bottles each contained less than the declared concentration of morphine.  
 
The charge of tampering with a consumer product provides a sentence of up to 10 years in prison, three years of supervised release and a fine of up to $250,000. Sentences are imposed by a federal district judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

Acting United States Attorney Joshua S. Levy; Fernando McMillan, Special Agent in Charge of the Food and Drug Administration, Office of Criminal Investigations; Roberto Coviello, Special Agent in Charge of the Department of Health and Human Services, Office of the Inspector General; and Robert H. Goldstein, MD, PhD, Commissioner of the Massachusetts Department of Public Health made the announcement. Assistant U.S. Attorney Lauren A. Graber of the Health Care Fraud Unit is prosecuting the case.

Back to Top